Actual Medicinal Product (AMP) - Inlyta 5mg tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Inlyta 5mg tablets | Start Date 29-10-2012 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 08010500 | Start Date 21-05-2013 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 21505811000001102 | 29-10-2012 |
Parent Products
-
VTMAxitinib
-
VMPAxitinib 5mg tablets
-
AMP(Current) Inlyta 5mg tablets (Pfizer Ltd) (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 56 tablet | 351700 |